Described here is a staged, behavioral screening approach that can be used to screen for compounds that exhibit in vivo efficacy on cognitive and functional motor behaviors in transgenic mouse models of β-amyloidosis and tauopathy. These methods are optimized to screen compounds for activity in short-term and working memory tasks.
Here we describe a staged, behavioral testing approach that can be used to screen for compounds that exhibit in vivo efficacy on cognitive and functional motor behaviors in transgenic mouse models of β-amyloidosis and tauopathy. The paradigm includes tests for spontaneous alternation in a Y-maze, novel object recognition, and limb clasping. These tests were selected because they: 1) interrogate function of cognitive or motor domains and the correlate neural circuitry relevant to the human disease state, 2) have clearly defined endpoints, 3) have easily implementable quality control checks, 4) can be run in a moderate throughput format, and 5) require little intervention by the investigator. These methods are designed for investigators looking to screen compounds for activity in short-term and working memory tasks, or functional motor behaviors associated with Alzheimer’s disease mouse models. The methods described here use behavioral tests that engage a number of different brain regions including hippocampus and various cortical areas. Investigators that desire cognitive tests that specifically assess cognition mediated by a single brain region could use these techniques to supplement other behavioral tests.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder resulting in debilitating cognitive decline that affects approximately 44 million people worldwide. Currently there are no available treatments for AD that are disease-modifying, emphasizing the urgent need for preclinical discovery of novel therapeutic strategies for this disease. A number of different transgenic mouse models have been created that recapitulate various aspects of AD1,2, including deficits in cognitive domains disrupted in patients3. These mouse models represent a useful tool for facilitating efficient screening in vivo.
When assessing a compound for potential in vivo efficacy, a staged approach must be taken that screens for efficacy in appropriate cognitive domains and also monitors behaviors that could influence the specific endpoints used to assess cognition. Many transgenic mouse models of AD exhibit hyperactivity and other behaviors that may interfere with a particular cognitive test, and prohibit its use in drug screening4. Moreover, for an approach to be implemented in a drug screening environment, the particular tests used should sustain at least a moderate throughput, have clearly defined endpoints, and a procedure that requires minimal intervention by the investigators. Using these criteria, behavioral screens can be implemented that exhibit the reproducibility, low intra- and inter-assay variance and effect sizes needed for compound screening. Detailed here are the methods we have employed to screen for compounds effective in mitigating the cognitive and motor phenotypes present in transgenic mouse models of β-amyloidosis and tauopathy5,6. The methods described are adapted from commonly used behavioral paradigms reported in the literature7, with specific optimizations and quality control checks so that they may be used in transgenic mouse models relevant to AD. This protocol can be used with a variety of data acquisition and analysis systems and assumes that the investigator has a working knowledge of the associated software.
The methods detailed in this publication were reviewed by the institutional animal care and use committee (IACUC) at Hilltop Laboratory Animals to ensure proper care, use, and humane treatment of animals in compliance with applicable federal, state, and local laws and regulations, such as the federal Animal Welfare Regulations, or AWRs (CFR 1985), and Public Health Service Policy on Humane Care and Use of Laboratory Animals, or PHS Policy (PHS 1996).
1. General Guidelines for all Behavioral Assessment
2. Habituating Mice to Handling by Investigators
3. Assessing Spatial Working Memory by Measuring Spontaneous Alternation in a Y-maze8
4. Assessment of Intermediate-term Recognition Memory by Measuring Novel Object Recognition11,12,13
5. Assessment of Corticospinal Function in Mice with Limb Clasping14
Table 1: Description of Limb Clasping Scores.
Aged Tg2576 mice exhibit robust deficits in spontaneous alternations made within a Y-maze15,16, a phenotype that can be replicated using the methods detailed here (Figure 1A). While a trend for increased arm entries is observed in these mice (Figure 1B), the hyperactivity observed in this line of mice did not affect the spontaneous alternation rate (Figure 1C). In contrast, aged rTg4510 mice appear to exhibit increased spontaneous alternation when placed into a Y-maze (Figure 1D). This is due to extreme hyperactivity (Figure 1E) and stereotypy10, which significantly interfere with measurement of spontaneous alternation (Figure 1F). When initially assessing mice in this task, it is critical to ensure that arm entries and/or distance traveled is not significantly correlated with the spontaneous alternation rate.
Prior to assessment of novel object recognition, mice are habituated to the arena where the test will be performed. During the habituation, hyperactivity (Figure 2A) and other stereotyped behaviors relevant to the mouse model can be assessed. During the sample phase, it is critical to measure exploration of each object separately so that mice that exhibit significant biases in exploratory behavior can be excluded from further assessment (Figure 2B, open circles). Novel object recognition is assessed by comparing exploration of a familiar and novel object, and is commonly analyzed in three different ways. If total exploratory time is comparable across genotypes and/or treatment groups, then raw time exploring each object and an appropriate repeated measures tests can be used to determine if there were differences in novel object recognition (Figure 2C). If a particular mouse strain exhibits differences in total exploratory time, novel object recognition can be assessed using either novelty preference (Figure 2D) or discrimination index (Figure 2E).
Limb clasping is a functional motor test that quantifies deficits in corticospinal function. Limb clasping, which is not a cognitive measure, is observed in several transgenic tau mouse models6,17,18,19 and recapitulates some of the functional motor deficits observed in late-stage AD patients. Suspension of mice by the tail elicits an escape response (Figure 3A, "0"). Deficits in the ability to splay the hind limbs and extend the toes are scored based on their severity on a scale from 0-4 (Figure 3A). Using the procedure outlined herein, one can observe significant limb clasping in rTg4510 mice (Figure 3B).
Figure 1: Spontaneous Alternation in the Y-maze. (A) When placed into a Y-maze, mice adopt a lose-shift search strategy that results in a pattern of exploration whereby each arm is explored just once for every 3 arm entries. Aged Tg2576 mice exhibit a significant deficit in spontaneous alternation. Using the procedures outlined in this method, a significant restoration of spontaneous alternation was observed after treatment with a proprietary compound. Data was analyzed using 1-way ANOVA and post-hoc comparisons to Tg-PBS were performed using Dunnett's test. **p <0.01. Error bars indicate SEM. (B) Number of arm entries was not significantly different across any of the groups monitored in this experiment. Data was analyzed using 1-way ANOVA test. Error bars indicate SEM. (C) There was no correlation between spontaneous alternation and the number of arm entries made, indicating that any differences in spontaneous locomotor activity did not impact quantification of spontaneous alternation. Correlation test was performed using Pearson's correlation analysis. (D) When placed into a Y-maze, rTg4510 mice (6 month) appear to exhibit significantly more spontaneous alternation relative to littermate WT mice. Data was analyzed by 1-way ANOVA and post-hoc comparisons to Tg-PBS were performed using Dunnett's test. **p <0.01. Error bars indicate SEM. (E) rTg4510 mice made significantly more arm entries due to their extreme hyperdynamic locomotion. Data was analyzed by 1-way ANOVA and post-hoc comparisons to Tg-PBS were performed using Dunnett's test. ***p <0.001. Error bars indicate SEM. (F) Spontaneous alternation behavior significantly correlated with arm entries, indicating the hyperdynamic locomotor phenotype obscured true spontaneous alternation. Correlation test was performed using Pearson's correlation analysis (r = 0.7, p <0.0001). Please click here to view a larger version of this figure.
Figure 2: Novel Object Recognition. (A) Arena habituation permits measurement of spontaneous locomotion and other stereotyped behaviors relevant to a particular mouse model. Here, aged Tg2576 mice (22 month) exhibit significantly more spontaneous locomotion relative to littermate WT mice. Data was analyzed by 1-way ANOVA and post-hoc comparisons to Tg-Veh were performed using Dunnett's test. **p <0.01. Error bars indicate SEM. (B) During sample phase, exploration of two identical objects was tracked separately. Mice that exhibit large biases toward exploration of one of the two objects (open circles) were excluded from test phase. (C–E) Novel object recognition was assessed by measuring the exploration of a novel and familiar object. Novel object recognition was assessed using (C) raw exploration time, (D) novelty preference or (E) discrimination index. Data in panel C were analyzed using a 2-way ANOVA with repeated measures and pairwise comparisons were made using Sidak's test. Data in panels D-E were analyzed with a 1-way ANOVA and post-hoc comparisons to Tg-Veh were made using Dunnett's test. *p <0.05, **p <0.01. Error bars indicate SEM. Please click here to view a larger version of this figure.
Figure 3: Limb Clasping. (A) Representative images of mice exhibiting various degrees of limb clasping as described in Table 1. (B) rTg4510 mice (6 month) exhibit significant limb clasping relative to littermate WT mice as scored using these methods. Data were analyzed using a 1-way ANOVA and post-hoc comparisons to Tg-PBS were performed using Dunnett's test. ***p <0.001, ****p <0.0001. Error bars indicate SEM. Please click here to view a larger version of this figure.
Significance of the Technique with Respect to Existing Methods
This procedure has been designed to screen for in vivo activity of compounds in transgenic mouse models of β-amyloidosis and tauopathy. The staged approach employed here ensures detection of efficacious compounds in cognitive domains relevant to AD3. Moreover, the approach detailed here uses behavioral tests that have clearly defined endpoints, easily implementable quality control checks, can be run in a moderate throughput format, and require little intervention from the investigator. These characteristics result in assays that exhibit good reproducibility within animals and across cohorts, which results in low intra- and inter-assay variance and effect sizes (2 ≤f ≤6) that are robust enough to support behavioral profiling in a drug discovery environment.
Critical Steps within the Protocol
Many mouse models in use for AD drug discovery exhibit behaviors consistent with heightened anxiety and aggression. This makes handling habituation essential for performing any of the behavioral tests described here. As these tests rely on unmotivated behaviors, rough handling by the investigator due to a hyperactive and anxious or aggressive mouse can significantly influence performance. Heightened anxiety could result in failure to perform the task, reducing the overall power of the test. Moreover, light levels in the arena are essential for facilitating the spontaneous locomotion needed for each test. Bright light tends to increase anxiety and suppress locomotion in rodents, therefore care should be taken to adjust ambient light levels to 30-35 lux in the arena.
Another critical aspect of the procedure is minimization of strong environmental cues that would interfere with an animal's ability to perform the tasks. Cleaning of the arena and objects in between runs is essential as mice are attracted to novel scents in the environment. Failure to thoroughly clean the arena and objects could result in skewing spontaneous activity of the mouse and masking true cognitive performance. Investigators should also minimize use of personal hygiene products and colognes/perfumes when performing these procedures. Lastly, rodents exhibit robust diurnal and circadian changes in many overt behaviors20 including learning and memory21. Therefore, to minimize variance due to diurnal rhythms in basal behaviors and cognitive performance, all tests should be done at the same time of day across cohorts and studies.
Further, specifically with regard to novel object recognition, the delay interval between sample and test phase, and the selection and placement of objects in the environment are critical parameters. Memory exists in 3 distinct forms: short term memory (STM), intermediate term memory (ITM) and long term memory (LTM)22,23. Changing the interval between sample and test phases from minutes (STM) to hours (ITM) or days (LTM) will change the type of memory tested by the procedure12. Moreover, prior to running the novel object recognition test, many objects should be screened in a test cohort of mice for potential biases in exploration. An object that is excessively attractive or repulsive to the test cohort cannot be used when assessing novel object recognition. Ideally all objects that will be employed in the test, when placed into an arena, will elicit equal exploration times from a naïve cohort of mice. Inadequate testing and optimization of objects can significantly reduce the power of novel object recognition.
Modifications and Troubleshooting
There are several factors that could increase the apparent variability in the cognitive tests described here. Many mouse models of AD exhibit hyperdynamic locomotion3 which can mask or alter behaviors measured as the cognitive endpoint. Moreover, there is growing evidence that sex24,25,26 and even maternal genotype27 can influence development and progression of neuropathology and cognitive phenotypes in AD mouse models. Unexpected variability or failure to implement a behavioral task could be due to any of these factors. When first implementing a particular behavioral test, results should always be stratified by sex, age and if applicable, maternal genotype. Furthermore, the quality checks outlined in this procedure should always be performed to ensure that hyperactivity or other stereotyped behaviors are not interfering with quantification of cognitive endpoints.
Environment can also influence the spontaneous exploratory behavior of rodents. Scents or sounds that are undetectable to researchers could attract or repel mice, skewing results of cognitive tests that rely on spontaneous behavior. When initially establishing Y-maze or novel object recognition, performance of the control measures to ensure that there are no positional biases in exploration of objects and/or the environment is essential. If positional biases are observed then investigators must thoroughly scrutinize the environment and potentially adjust lighting, arena placement, location of testing room relative to other rooms in the facility (i.e., not near a high traffick area or heavy equipment) and arena cleaning procedures.
Habituation to the testing environment is key to achieving optimal performance in the novel object recognition test. For example, low total exploration times may be due to inadequate habituation. As an alternative to the procedures outlined here for handling (Section 2) and arena (Section 4.2) habituation, habituation to handling and the test environment can be performed as 3, 5 min sessions per day for 2 consecutive days.
Limitations of the Technique
As with any procedure, these behavioral tests have limitations. These procedures have been employed because they test function of various cortical regions and hippocampus. If the mouse model does not exhibit functional deficits in brain regions probed by these tests, then these techniques will not be useful. Moreover, we have chosen cognitive tests that probe short-term memory. If the mechanism of action of the compound under preclinical assessment is not expected to affect short-term memory then these procedures should be modified accordingly (i.e., increasing the sample-test phase interval to test long-term memory). Lastly, these tests use unmotivated behaviors. Therefore, if a mouse model is excessively hyperactive or displays other stereotyped behaviors that prevent exploration of the environment then these procedures might not be optimal. As an alternative, one could use fear conditioning for Tg2576 or other β-amyloidosis mouse models, or the spatial water maze for rTg4510 or other mouse models of tauopathy3.
Future Applications
Once these procedures have been successfully adopted in the lab, several modifications or extensions can be made to assess additional cognitive and functional motor measures. For example, changing the novel object recognition task to determine if a mouse can recognize a change in placement of an object13. Alternatively, instead of using objects, one could use other mice and implement a test of social recognition. With respect to limb clasping and motor function, one could supplement that test with the wire hang and/or grip strength tests. The tests detailed in this method form a solid base to screen for compounds that have in vivo efficacy in translational mouse models for AD, and can be adapted or modified in many ways to best interrogate a particular mouse model or meet the needs of a unique drug discovery program.
The authors have nothing to disclose.
The authors have no acknowledgements.
Topscan Lite-High Throughput | Cleversys | Automated behavioral analysis. Includes cameras and video acquisition system, laptop. | |
ObjectScan | Cleversys | Software module for accurate object exploration quantification | |
Open field for mouse | Cleversys | CSI-OF-M | Arena for novel object recognition |
Y-maze for mouse | Custom | Arms: 30cm long, 10 cm wide, 20cm high walls, placed 120deg apart. | |
Camera mount for open field | Custom | Custom | 76 cm tall, 115 cm wide, cameras mounted @ 30cm in from either side. Two mounts, each covers two boxes. |
Camera mount for Y-maze | Custom | Custom | 76 cm tall, 115 cm wide, cameras mounted @ 30cm in from either side. One mount covers two mazes. |
Marbles | Inperial Toy | 8565 | Standard (15.5mm Dia) glass marbles. |
Dice | Cardinal Industries | 770 | Standard (0.650 inch) white dice with black dots. |
LOCTITE Fun-Tak | Henkel | B018A3AG0W | Standard blue sticky tak |
EtOH | Nexeo Solutions | 82452 | 100% Ethanol Diluted to 70% using distilled Water |
dH2O | Tulpenhocken Spring Water Co. | – | PA D.E.P. #31, NJ D.O.H. #0049, NYSHD Cert. #320 |
Paper towels | Procter & Gamble | B019DM86LA | Bounty, White |
Handheld video camera | Apple, Inc. | MKV92LL/A | Acquisition of Limb clasping video, Iphone 6S Plus (or functional equivalent). |
Gloves | SafePOINT, L.L.C. | GL640-2 | Standard, Powder free Latex Gloves, Medium |
Light meter | Dr. Meter | LX1330B | Lighting @ the bottom of Open Field= 35 LUX, Lighting @ bottom of Y-Maze= 32 LUX |
Bleach germicidal wipes | Clorox | Sterilization of equipment during & after use |